Emerging Technologies in Drug Discovery and Development

Shanghai, June/September, 2021. Dates available soon!

Scientific and Organizing Committee

  1. Alex Avdeef, in-ADME reserach, US
  2. Rolf Hilfiker, Solvias AG, Switzerland
  3. Zoran Mandić, University of Zagreb, Croatia (co-chair)
  4. Godefridus J. Peters, UV University Medical Center Amsterdam, The Netherlands
  5. Abu Serajuddin, St. John's university, US
  6. Kiyohiko Sugano, Ritsumeikan University, Japan
  7. Kin Tam, University of Macau, China (co-chair)
  8. Hong Wan, Sironax, Beijing, China (co-chair)

 

Local Organizing committee

  1. Qiyue Hu (胡齐悦), Shanghai Hengrui Pharmaceutical Co., Ltd. (Hengrui Medicine), China
  2. Zhuohan Hu (胡卓汉), Research Institute for Liver Diseases (Shanghai) Co., Ltd. (RILD), China
  3. Jingwu Kang (康经武), Shanghai Institute of Organic Chemistry (SIOC), Chinese Academy of Sciences (CAS)
  4. Yan Li (李艳), Shanghai Hengrui Pharmaceutical Co., Ltd. (Hengrui Medicine)
  5. Kin Tam (谭建业), University of Macau, China
  6. Hong Wan (万宏), Sironax, Beijing, China (chair)
  7. Jiaying Wang (王佳英), Shanghai Hengrui Pharmaceutical Co., Ltd. (Hengrui Medicine), China
  8. Changyong Yang (杨昌永), Shanghai Hengrui Pharmaceutical Co., Ltd. (Hengrui Medicine), China
  9. Lei Zhang (张蕾), Shanghai Hengrui Pharmaceutical Co., Ltd. (Hengrui Medicine), China
  10. Dafang Zhong (钟大放), Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Science (CAS)
  11. Min Hu (胡旻), Shanghai Hengrui Pharmaceutical Co., Ltd. (Hengrui Medicine), China
  12. Hua Lv (吕华), Jiangsu Hengrui Medicine Co., Ltd.  China